Advertisement
U.S. markets close in 1 hour 18 minutes

Revance Therapeutics, Inc. (RVNC)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
4.8800-0.0600 (-1.21%)
As of 02:42PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close4.9400
Open5.0000
Bid4.8600 x 1000
Ask4.9100 x 100
Day's Range4.8650 - 5.0300
52 Week Range4.5700 - 37.9800
Volume597,024
Avg. Volume1,830,765
Market Cap508.574M
Beta (5Y Monthly)1.09
PE Ratio (TTM)N/A
EPS (TTM)-3.8300
Earnings DateMay 06, 2024 - May 21, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est14.91
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for RVNC

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Revance Therapeutics, Inc.
    Daily – Vickers Top Buyers & Sellers for 05/17/2023The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    10 months agoArgus Research
View more